Advanced search
Publication Cover
mAbs Volume 12, 2020 - Issue 1
Submit an article Journal homepage
2,219
Views
10
CrossRef citations to date
0
Altmetric
Report

Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo

Lisa Nadala Biology department, Philochem AG, Otelfingen, Switzerland;b CiBIO (Department of Cellular, Computational and Integrative Biology, University of Trento, Italy, Trento, ItalyORCID Iconhttps://orcid.org/0000-0002-8566-103XView further author information
ORCID Icon,
Riccardo Corbellaria Biology department, Philochem AG, Otelfingen, Switzerland;b CiBIO (Department of Cellular, Computational and Integrative Biology, University of Trento, Italy, Trento, ItalyORCID Iconhttps://orcid.org/0000-0001-6126-5641View further author information
ORCID Icon,
Alessandra Villaa Biology department, Philochem AG, Otelfingen, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-4070-286XView further author information
ORCID Icon,
Tobias Weissc Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, SwitzerlandView further author information
,
Michael Wellerc Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Zurich, SwitzerlandView further author information
,
Dario Nerid Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, SwitzerlandORCID Iconhttps://orcid.org/0000-0001-5234-7370View further author information
ORCID Icon &
Roberto De Lucaa Biology department, Philochem AG, Otelfingen, SwitzerlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7519-8689View further author information
ORCID Icon show all
Article: 1836713 | Received 18 May 2020, Accepted 10 Oct 2020, Published online: 02 Nov 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Louis Plüss, Frederik Peissert, Abdullah Elsayed, Giulia Rotta, Jonas Römer, Sheila Dakhel Plaza, Alessandra Villa, Emanuele Puca, Roberto De Luca, Annette Oxenius & Dario Neri. (2023) Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen. mAbs 15:1.
Read now

Articles from other publishers (9)

Wujun Chen, Yudong Wu, Jie Wang, Wanpeng Yu, Xin Shen, Kai Zhao, Bing Liang, Xiaokun Hu, Shuai Wang, Hongfei Jiang, Xinlin Liu, Miao Zhang, Xiaohui Xing, Chao Wang & Dongming Xing. (2023) Clinical advances in TNC delivery vectors and their conjugate agents. Pharmacology & Therapeutics, pages 108577.
Crossref
Frederik Peissert, Mattia Pedotti, Riccardo Corbellari, Luca Simonelli, Raoul De Gasparo, Elia Tamagnini, Louis Plüss, Abdullah Elsayed, Mattia Matasci, Roberto De Luca, Irene Cassaniti, Jose’ Camilla Sammartino, Antonio Piralla, Fausto Baldanti, Dario Neri & Luca Varani. (2023) Adapting Neutralizing Antibodies to Viral Variants by Structure‐Guided Affinity Maturation Using Phage Display Technology. Global Challenges.
Crossref
Nan Han & Zhaoqi Liu. (2023) Targeting alternative splicing in cancer immunotherapy. Frontiers in Cell and Developmental Biology 11.
Crossref
Noor Jailkhani, Karl R. Clauser, Howard H. Mak, Steffen Rickelt, Chenxi Tian, Charles A. Whittaker, Kenneth K. Tanabe, Stephen R. Purdy, Steven A. Carr & Richard O. Hynes. (2023) Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. Cancer Research 83:12, pages 2052-2065.
Crossref
Thomas Look, Emanuele PucaMarcel Bühler, Daniel Kirschenbaum, Roberto De Luca, Riccardo StucchiDomenico RavazzaCesare Di NittoPatrick Roth, Yonatan Katzenelenbogen, Assaf Weiner, Lukas Rindlisbacher, Burkhard Becher, Ido Amit, Michael Weller, Dario NeriTeresa Hemmerle & Tobias Weiss. (2023) Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma. Science Translational Medicine 15:697.
Crossref
Sheila Dakhel, Andrea Galbiati, Francesca Migliorini, Claudia Comacchio, Sebastian Oehler, Luca Prati, Jörg Scheuermann, Samuele Cazzamalli, Dario Neri, Gabriele Bassi & Nicholas Favalli. (2022) Isolation of a Natural Killer Group 2D Small‐Molecule Ligand from DNA‐Encoded Chemical Libraries. ChemMedChem 17:21.
Crossref
Lisa Nadal, Frederik Peissert, Abdullah Elsayed, Tobias Weiss, Thomas Look, Michael Weller, Geny Piro, Carmine Carbone, Giampaolo Tortora, Mattia Matasci, Nicholas Favalli, Riccardo Corbellari, Cesare Di Nitto, Eleonora Prodi, Chiara Libbra, Simone Galeazzi, Claudiopietro Carotenuto, Cornelia Halin, Emanuele Puca, Dario Neri & Roberto De Luca. (2022) Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody . Journal for ImmunoTherapy of Cancer 10:9, pages e005282.
Crossref
Zaixiang Fu, Ganggui Zhu, Chao Luo, Zihang Chen, Zhangqi Dou, Yike Chen, Chen Zhong, Sheng Su & Fuyi Liu. (2022) Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment. Frontiers in Oncology 12.
Crossref
Swati Bhattacharyya, Kim S. Midwood & John Varga. (2022) Tenascin-C in fibrosis in multiple organs: Translational implications. Seminars in Cell & Developmental Biology 128, pages 130-136.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.